Abirateron Sandoz 250 mg filmom obložene tablete
| Name | Abirateron Sandoz 250 mg filmom obložene tablete |
|---|---|
| Marketing Authorisation Number | HR-H-359653549 |
| Active Substance | abirateronacetat |
| Composition | svaka filmom obložena tableta sadrži 250 mg abirateronacetata |
| Pharmaceutical Form | filmom obložena tableta |
| Manufacturer | Lek Pharmaceuticals d.d., Ljubljana, Slovenija
Remedica Ltd., Limassol, Cipar |
| Marketing Authorisation Holder | Sandoz d.o.o., Maksimirska 120, Zagreb, Hrvatska |
| Marketing Authorisation Date | 01.07.2021 |
| MA Period of Validity | 01.07.2026 |
| Classification Number | UP/I-530-09/19-01/271 |
| Registration Number | 381-12-01/154-21-04 |
| Prescription | na recept |
| Type of prescription | ograničeni recept |
| Distribution | u ljekarni |
| Advertising to general public | zabranjeno |
| ATC Code | L02BX03 |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
